Thomas McNaughton

CIK 1449450 · Chief Financial Officer · last filed 2019-06-18

Thomas McNaughton is a Chief Financial Officer who has filed 27 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for EYEGW, was dated Jun 18, 2019. Across all open-market trades the lifetime net is +$222.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.04M

Companies

4

Total Filings

27

Lifetime Open-Market Net

$222.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Harvard Apparatus Regenerative Technology, Inc. (EYEGW) Delisted Chief Financial Officer 13,734 $11.0K 5 2019-06-18
Harvard Apparatus Regenerative Technology, Inc. (BSTG) Delisted Chief Financial Officer 206,128 $7.8K 1 2016-05-23
Harvard Apparatus Regenerative Technology, Inc. (HART) Delisted Chief Financial Officer 201,128 $30.67 $6.17M $203.3K 13 2016-03-24
HBIO Chief Financial Officer 171,613 $6.08 $1.04M $0 8 2013-11-05

Recent Filings

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-06-18 Harvard Apparatus Regenerative Technology, Inc. (EYEGW) Delisted Grant (A) $0 EDGAR
2018-06-19 Harvard Apparatus Regenerative Technology, Inc. (EYEGW) Delisted Buy (P) +2,500 $11.0K EDGAR
2018-05-31 Harvard Apparatus Regenerative Technology, Inc. (EYEGW) Delisted Grant (A) $0 EDGAR
2018-03-28 Harvard Apparatus Regenerative Technology, Inc. (EYEGW) Delisted Exer (M) +928 $0 EDGAR
2017-03-16 Harvard Apparatus Regenerative Technology, Inc. (EYEGW) Delisted Grant (A) $0 EDGAR
2016-05-23 Harvard Apparatus Regenerative Technology, Inc. (BSTG) Delisted Buy (P) +5,000 $7.8K EDGAR
2016-03-24 Harvard Apparatus Regenerative Technology, Inc. (HART) Delisted Grant (A) $0 EDGAR
2015-11-19 Harvard Apparatus Regenerative Technology, Inc. (HART) Delisted Buy (P) +10,000 $17.0K EDGAR
2015-11-18 Harvard Apparatus Regenerative Technology, Inc. (HART) Delisted Buy (P) +10,000 $15.6K EDGAR
2015-11-17 Harvard Apparatus Regenerative Technology, Inc. (HART) Delisted Buy (P) +15,000 $19.8K EDGAR
Showing 110 of 27
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.